Andrew Coats

DM, DSc, MBA, AO
President, Heart Failure Association of the ESC,
Professor of Cardiology,
University of Warwick, Coventry, UK and Monash University, Melbourne, Australia,

Andrew Coats

Andrew was born in Melbourne, Australia and studied Medicine at Oxford and Cambridge. He has published over 20 patents and more than over 650 peer-reviewed research papers. He has more than 100,000 career citations, and a personal H-index of 135.

He served as Editor-in-Chief of the International Journal of Cardiology from 1999 to 2016 and has served on more than 10 major journal editorial boards. Andrew is an expert on heart failure. He first described the Muscle Hypothesis of Chronic Heart Failure that explained dyspnoea and exaggerated

ventilatory responses in CHF patients. He first described chemoreflex overactivity in CHF and periodic breathing and published the first ever randomised trial of exercise training for CHF.

Andrew has been Chairman or Committee member of the following major Cardiovascular and Cancer Cachexia Clinical Trials: CHRISTMAS, CHARM, COPERNICUS, OXAM, OPTIMAAL, OVERTURE, REPLACE, SENIORS, AUGMENTHF and ACT-ONE. He has served as Head of Cardiology at Imperial College and Director of Cardiology at Royal Brompton Hospital, London then as Dean of Medicine and Deputy

Vice-President at the University of Sydney, and as Joint Academic Vice-President of Monash University, Australia and the University of Warwick, UK. He is President of the Heart Failure Association of the ESC.